Visanne cleared for market launch in Europe as new treatment option for endometriosis
Wednesday, December 09, 2009 09:00 IST Berlin
Bayer Schering Pharma AG, Germany, has successfully completed the decentralized part of drug approval procedure in Europe for a new treatment of endometriosis called Visanne.